生物医药科研

Search documents
AI算力助复旦科研再突破:阿尔茨海默病早筛早诊检测试剂年内或上线
Huan Qiu Wang Zi Xun· 2025-07-19 12:33
Core Viewpoint - Fudan University has made significant breakthroughs in the medical field, including the discovery of a new treatment target for Parkinson's disease and the upcoming launch of early screening and diagnostic testing for Alzheimer's disease, supported by AI computing power from the CFFF platform in collaboration with Alibaba Cloud [1][3]. Group 1: Breakthroughs in Alzheimer's and Parkinson's Disease - The research team led by Professor Yu Kintai has achieved a 15-year early prediction of Alzheimer's disease risk with over 98.7% accuracy, published in the journal Nature [3][5]. - The team has identified a new treatment target for Parkinson's disease and utilized AI to screen potential drugs, with findings published in top international journals such as Cell and Nature [3][5]. Group 2: CFFF Platform and AI Integration - The CFFF platform, launched in 2023, integrates advanced computing clusters and AI technologies, enabling researchers to process large datasets more efficiently than traditional methods [3][4]. - The platform supports over 1,000 parallel intelligent computations and facilitates the training of large models with billions of parameters, significantly enhancing research capabilities [3][4]. Group 3: Efficiency Improvements in Research - The use of AI and innovative data-driven methods has allowed the research team to analyze over 6,361 cerebrospinal fluid proteins, identifying five key proteins that improve diagnostic accuracy to 98.7% [4][5]. - AI technology has accelerated the identification of potential therapeutic targets in Parkinson's disease, completing in five years what would traditionally take decades [5].
美国生物医药数据库对华“断链”,中国科研人员呼吁开放原始数据
Hu Xiu· 2025-04-22 11:33
当地时间4月15日,UK BioBank(英国生物药学数据库)在其官网发布了一则名为《A message to our participants:why researchers in China can access our data》(《致各位参与者的一封信:为何中国的研究人员能够获取我们的数据》)的告示,从用途、用户反馈和代表人物的发言,表明了该数据库在科研 领域的重要性。该文还谈道,目前全球60多个国家/地区的20000多名科学家正在使用该数据库的数据进行健康和疾病研究。 UK BioBank之所以发文,和几天前美国国家卫生研究院(NIH)发出的一项通知密切相关。NIH在通知中称,从今年4月4日起,禁止包括中国在内的一些 国家的科研机构访问NIH受控访问数据库及其相关数据,包括颇负盛名的美国国家癌症研究所(NCI)旗下的SEER数据库。毫无疑问,这和4月8日正式 实施的美国第14117号行政令密切相关。 SEER数据库被禁止访问的消息迅速在国内学术圈,尤其在生物医药学领域掀起波澜。有媒体声称科研"冷战"或将开始,关心中国科学家们该何去何从, 也有不少人担心其他地区的数据库会跟进限制中国用户访问。不过从U ...